IRCT2013021912527N1已完成2 期
Evaluating the effect of metformin on cyst volume and kidney volume in patients with Autosomal dominant polycystic kidney disease (ADPKD)
Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 14 years 至 85 years（—）
- 性别
- All
入选标准
- •Serum creatinine less than 1.4mg/dL at the beginning of the study; signing the informed consent form
- •Exclusion criteria:
- •previous history of metformin use; allergy to metformin; any side effect during the intervention which prevents the patient from continuing the study
排除标准
- 未提供
研究者
相似试验
尚未招募
4 期
Investigating the effects of metformin on growth factors involved in prostate cancer progression in prostate cancer patientsProstate cancerACTRN12615000778583Western Sydney Local Health District26
招募中
2 期
The effect of Metformin on complication of strokesStroke.Stroke, not specified as haemorrhage or infarctionIRCT20160318027097N5Vice Chancellor for research of Ardebil University of Medical Sciences100
已完成
不适用
The effects of metformin on anthropometric, metabolic and hormonal changes in polycystic ovarian syndromePolycystic ovarian syndrome.Polycystic ovarian syndromeIRCT138903244176N1Hamedan university of medical sciences/Pro vice chancellor for research28
未知
3 期
Analysis for effect of metformin on aberrant crypt foci (ACF)Subjects with aberrant crypt foci (ACF)JPRN-UMIN000001241Gastroenterology Division, Yokohama City University Graduate School of Medicine100
进行中（未招募）
1 期
Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.CTIS2024-511295-33-00Medica Scientia Innovation Research S.L.88